fmc-376,adagrasib,sotorasib
mirati therapeutics,amgen,frontier medicines
['lcsm,(-blcsm)', 'adagrasib', 'fmc-376', 'sotorasib']
new kras targeting drug fmc-376 blocks both active + inactive kras g12c forms. shows activity in preclinical cancer models resistant to current kras g12c drugs, sotorasib + adagrasib, &amp; active in multiple cancer types. #aacr23 #lcsm (9/11) 
LUNGevity, the nation’s leading lung cancer organization, is transforming what it means to be diagnosed and live with lung cancer.